Amrize Ltd (AMRZ) Price & Analysis

Compare

51 Followers

AMRZ Stock Chart & Stats

Day’s Range― - ―

52-Week Range$44.12 - $56.29

Previous CloseN/A

VolumeN/A

Average Volume (3M)4.91M

Market Cap

$26.05B

Enterprise Value$33.98B

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.09

Next Earnings

Oct 29, 2025

EPS Estimate

1.02

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.78

Shares Outstanding552,735,960

10 Day Avg. Volume3,963,707

30 Day Avg. Volume4,908,042

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap1.30

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$59.00

Price Target Upside20.53% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering9

Bulls Say, Bears Say

Bulls Say

Growth DriversPositive drivers include potential inclusion in multiple U.S. indices, a large and accretive M&A transaction, and an aggressive share buyback program.

Investment PotentialThe company's robust EBITDA growth prospects, both organic and inorganic, coupled with a strong free cash flow conversion rate of over 50%, make it an attractive investment.

Market PositionAmrize's dominant position and exposure to structurally strong inland markets gives superior pricing power.

Bears Say

Market WeaknessThe stock has been weak since the spin due to the softness in the US market and some initial flowback from dividend, ESG and Swiss funds, providing an excellent opportunity to buy this quality stock.

Regulatory RiskThere is risk that the next transportation spending bill does not get smoothly reauthorized once IIJA expires.

Amrize Ltd News

Amrize initiated with an Overweight at Wells Fargo

Wells Fargo analyst Timna Tanners initiated coverage of Amrize with an Overweight rating and $57 price target The...

3d ago

AMRZ

Amrize initiated with an Equal Weight at Barclays

Barclays initiated coverage of Amrize (AMRZ) with an Equal Weight rating and CHF 41 price target The company’s...

4d ago

AMRZ

Amrize management to meet with Truist

Meeting to be held in Boston on September 17 and in Toronto on September 18 hosted by Truist....

24d ago

AMRZ

Amrize price target raised to $65 from $62 at Bernstein

Bernstein raised the firm’s price target on Amrize (AMRZ) to $65 from $62 and keeps an Outperform rating...

29d ago

AMRZ

Amrize Ltd to Release Q3 2025 Financial Results on October 28

Amrize Ltd ( ($AMRZ) ) just unveiled an announcement. Amrize Ltd has announced that it will release its...

2d ago

AMRZ

Amrize initiated with an Outperform at Oppenheimer

Oppenheimer analyst Bryan F. Blair initiated coverage of Amrize (AMRZ) with an Outperform rating and $62 price target...

1M ago

AMRZ

Amrize recommends shareholders reject mini-tender offer from TRC Capital

Amrize (AMRZ) has received a notice of an unsolicited “mini-tender” offer by TRC Capital Investment, or TRC, to...

1M ago

AMRZ

Amrize Advises Against TRC Capital’s Mini-Tender Offer

Amrize Ltd ( ($AMRZ) ) just unveiled an update. Amrize Ltd has advised its shareholders to reject an...

1M ago

AMRZ

Amrize price target raised to $60 from $52 at JPMorgan

JPMorgan raised the firm’s price target on Amrize (AMRZ) to $60 from $52 and keeps an Overweight rating...

2M ago

AMRZ

Amrize Ltd Reports Resilient Q2 2025 Performance

Amrize Ltd ( ($AMRZ) ) has released its Q2 earnings. Here is a breakdown of the information Amrize...

2M ago

AMRZ

Amrize price target lowered to $54 from $61 at RBC Capital

RBC Capital analyst Anthony Codling lowered the firm’s price target on Amrize (AMRZ) to $54 from $61 but...

2M ago

AMRZ

Amrize Ltd Reports Q2 2025 Financial Results

Amrize Ltd ( ($AMRZ) ) has shared an update. Amrize Ltd reported its second quarter 2025 financial results,...

2M ago

AMRZ

Amrize reports Q2 EPS 78c vs 86c last year

Reports Q2 revenue $3.22B, consensus $3.39B. Jan Jenisch, Chairman and CEO: “We successfully listed Amrize (AMRZ) on the...

2M ago

AMRZ

Amrize sees FY25 revenue $11.4B-$11.8B, consensus $11.89B

Sees FY25 adjusted EBITDA $2.9B-$3.1B Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...

2M ago

AMRZ

AMRZ FAQ

What was Amrize Ltd’s price range in the past 12 months?

Amrize Ltd lowest stock price was $44.12 and its highest was $56.29 in the past 12 months.

What is Amrize Ltd’s market cap?

Amrize Ltd’s market cap is $26.05B.

When is Amrize Ltd’s upcoming earnings report date?

Amrize Ltd’s upcoming earnings report date is Oct 29, 2025 which is in 18 days.

How were Amrize Ltd’s earnings last quarter?

Amrize Ltd released its earnings results on Aug 06, 2025. The company reported $0.78 earnings per share for the quarter, missing the consensus estimate of $1.15 by -$0.37.

Is Amrize Ltd overvalued?

According to Wall Street analysts Amrize Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Amrize Ltd pay dividends?

Amrize Ltd does not currently pay dividends.

What is Amrize Ltd’s EPS estimate?

Amrize Ltd’s EPS estimate is 1.02.

How many shares outstanding does Amrize Ltd have?

Amrize Ltd has 552,735,960 shares outstanding.

What happened to Amrize Ltd’s price movement after its last earnings report?

Amrize Ltd reported an EPS of $0.78 in its last earnings report, missing expectations of $1.15. Following the earnings report the stock price went down -6.719%.

Which hedge fund is a major shareholder of Amrize Ltd?

Currently, no hedge funds are holding shares in AMRZ

Amrize Ltd Stock Smart Score

Outperform

Company Description

Amrize Ltd

Amrize Ltd (AMRZ) is a technology-driven company specializing in innovative solutions for the healthcare and wellness sectors. Focused on improving patient outcomes and enhancing the efficiency of healthcare delivery, Amrize offers a range of products and services, including telehealth platforms, electronic health records (EHR) systems, and integrated health management solutions. Through its advanced technology, the company aims to streamline healthcare processes and empower both providers and patients.

Amrize Ltd (AMRZ) Earnings & Revenues

Historic Earnings Reports

AMRZ Company Deck

AMRZ Earnings Call

Q2 2025

0:00 / 0:00

AMRZ Stock 12 Month Forecast

Average Price Target

$59.00

▲(20.53% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"47":"$47","66":"$66","51.75":"$51.8","56.5":"$56.5","61.25":"$61.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":65,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$65.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":59,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$59.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":50,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$50.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[47,51.75,56.5,61.25,66],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,48.44,49.71384615384615,50.987692307692306,52.26153846153846,53.535384615384615,54.809230769230766,56.08307692307692,57.356923076923074,58.63076923076923,59.90461538461538,61.17846153846154,62.45230769230769,63.72615384615385,{"y":65,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,48.44,49.25230769230769,50.06461538461538,50.87692307692308,51.68923076923077,52.50153846153846,53.31384615384615,54.12615384615385,54.93846153846154,55.75076923076923,56.56307692307692,57.37538461538462,58.18769230769231,{"y":59,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,48.44,48.559999999999995,48.68,48.8,48.92,49.04,49.16,49.28,49.4,49.519999999999996,49.64,49.76,49.88,{"y":50,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":53,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.67,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.01,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.67,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.44,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >